Figure 2.
Errors associated with estimates of mean glycemia derived from CGM, HbA1c, and a combination of both. A: Mean absolute error (wider line) and the 95th percentile (fine line) of the distribution of absolute errors for eAGCGM calculated over different periods of time, with all ending at the same point, as compared with eAG90. Distinct monitoring periods of the same duration within the same 90-day period will have different calculated eAGCGM because of factors including healthy physiological glycemic fluctuations and sensor bias. B: Relative average glucose (AG) variation (%) between different 14-day monitoring periods. C: Comparison of theoretical constant MRBC regression lines with the ADAG study empirical regression line. D: Variation in eAGA1c for each fixed HbA1c as a result of nonglycemic factors like MRBC, with both the point estimate for eAGA1c (black dot) and its error distribution. The black vertical bars show the theoretical 95% CIs for eAG90 associated with each HbA1c value, as a result of modeled variation in MRBC. The theoretical error bars were calculated under the assumption that all nonglycemic variation in HbA1c is caused by changes in MRBC, with a population variation of 10–12% in MRBC (∼5 days), yielding the following CIs: For HbA1c: and for eAGA1c: . The shaded areas show empirical CIs for eAGA1c obtained in the ADAG study, (14), and in the study by Beck et al. (16). The similarity between the theoretical and empirical CIs supports the use of modeled MRBC as a proxy for all nonglycemic effects on HbA1c. See Supplementary Methods for details. E: The error expected when eAGA1c is averaged with eAGCGM. The mean absolute error of the average (left panel, black line) is lower than that for either eAGA1c or eAGCGM alone if <26 days of CGM data are available, and extreme errors are less frequent (right panel). AE, absolute error; MAE, mean absolute error.
